Leucine

Leucine

SCHEMBL1863461

CC(C)C[C@H](N)C(=O)O.CC(C)[C@H](N)C(=O)O.CC[C@H](C)[C@H](N)C(=O)O.C[C@H](N)C(=O)O

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 2/20 0.58
SLC1A2 P43004 7/20 0.47
SLC1A3 P43003 6/20 0.47
SLC1A1 P43005 7/20 0.44
GRIK1 P39086 11/20 0.39
GRIK2 Q13002 8/20 0.39
DPP4 P27487 1/20 0.35
DPP8 Q6V1X1 1/20 0.35
DPP9 Q86TI2 1/20 0.35
GRM1 Q13255 1/20 0.34
GRM2 Q14416 1/20 0.34
GRIA4 P48058 3/20 0.34
GRIK3 Q13003 3/20 0.34
GRIK5 Q16478 3/20 0.34
GRIA2 P42262 2/20 0.33
GRIA1 P42261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Leucine SCHEMBL7759799 1.00 SLC7A5 (0.58) SLC7A5SLC1A2SLC1A3SLC1A1GRIK1
Leucine SCHEMBL27689301 0.97 SLC7A5 (0.55) SLC7A5SLC1A2SLC1A3SLC1A1GRIK1
Leucine SCHEMBL28948522 0.97 SLC7A5 (0.62) SLC7A5SLC1A2SLC1A3SLC1A1GRIK1
Leucine SCHEMBL692565 0.97 SLC7A5 (0.62) SLC7A5SLC1A2SLC1A3SLC1A1GRIK1
Leucine SCHEMBL138874 0.97 SLC7A5 (0.62) SLC7A5SLC1A2SLC1A3SLC1A1GRIK1
Leucine SCHEMBL2408752 0.97 SLC7A5 (0.62) SLC7A5SLC1A2SLC1A3SLC1A1GRIK1
Leucine SCHEMBL26598008 0.95 SLC7A5 (0.64) SLC7A5SLC1A2SLC1A3SLC1A1GRIK1
Leucine SCHEMBL2551557 0.95 SLC7A5 (0.64) SLC7A5SLC1A2SLC1A3SLC1A1GRIK1
Leucine SCHEMBL9721406 0.95 SLC7A5 (0.64) SLC7A5SLC1A2SLC1A3SLC1A1GRIK1
Leucine SCHEMBL1162683 0.94 SLC7A5 (0.51) SLC7A5SLC1A2SLC1A3SLC1A1GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3074415-A1 NOVEL ULTRASHORT HYDROPHOBIC PEPTIDES THAT SELF-ASSEMBLE INTO NANOFIBROUS HYDROGELS AND THEIR USES Agency For Science, Technology And Research (SG) 2016-10-05 EP claimed
WO-2015080670-A1 NOVEL ULTRASHORT HYDROPHOBIC PEPTIDES THAT SELF-ASSEMBLE INTO NANOFIBROUS HYDROGELS AND THEIR USES AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2015-06-04 WO claimed
US-20230192775-A1 INFLUENZA VIRUS REPLICATION FOR VACCINE DEVELOPMENT WISCONSIN ALUMNI RESEARCH FOUNDATION 2023-06-22 US disclosed
CN-114929269-A Improved influenza virus replication for vaccine development 威斯康星校友研究基金会(WARF) 2022-08-19 CN disclosed
US-11390649-B2 Influenza virus replication for vaccine development WISCONSIN ALUMNI RESEARCH FOUNDATION (WARF) (US) 2022-07-19 US disclosed
EP-4008727-A1 ANTI-HUMAN P40 PROTEIN DOMAIN ANTIBODY AND USE THEREOF Akeso Biopharma Inc. (CN) 2022-06-08 EP disclosed
WO-2021195410-A1 RECOMBINANT MULTIVALENT INFLUENZA VIRUSES WISCONSIN ALUMNI RESEARCH FOUNDATION (WARF) (US) 2021-09-30 WO disclosed
US-20210061862-A1 INFLUENZA VIRUS REPLICATION FOR VACCINE DEVELOPMENT WISCONSIN ALUMNI RESEARCH FOUNDATION 2021-03-04 US disclosed
WO-2020223699-A1 IMPROVED INFLUENZA VIRUS REPLICATION FOR VACCINE DEVELOPMENT WISCONSIN ALUMNI RESEARCH FOUNDATION (WARF) (US) 2020-11-05 WO disclosed
CN-105189532-B Self-assembled ultrashort peptide hydrogels for wound healing, skin care and cosmetic applications 新加坡科技研究局 2020-11-03 CN disclosed
US-10293083-B2 Crosslinked peptide hydrogels AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2019-05-21 US disclosed
US-20130023460-A1 AMPHIPHILIC LINEAR PEPTIDE/PEPTOID AND HYDROGEL COMPRISING THE SAME AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2013-01-24 US disclosed
EP-2493912-A1 HIGH TITER RECOMBINANT INFLUENZA VIRUSES WITH ENHANCED REPLICATION IN VERO CELLS Wisconsin Alumni Research Foundation (US) 2012-09-05 EP disclosed
WO-2011123061-A1 AMPHIPHILIC LINEAR PEPTIDE/PEPTOID AND HYDROGEL COMPRISING THE SAME AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2011-10-06 WO disclosed
WO-2011056591-A1 HIGH TITER RECOMBINANT INFLUENZA VIRUSES WITH ENHANCED REPLICATION IN VERO CELLS WARF - WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2011-05-12 WO disclosed
EP-1097173-A1 PEPTIDES OF IL-2 AND DERIVATIVES THEREOF AND THEIR USE AS THERAPEUTIC AGENTS INSTITUT PASTEUR (FR) 2001-05-09 EP disclosed
EP-0804559-A4 ENZYME FOR CLEAVAGE OF THE ANCHOR REGION OF SURFACE PROTEINS FROM GRAM POSITIVE BACTERIA UNIV ROCKEFELLER (US) 2000-05-31 EP disclosed
WO-2000004048-A1 PEPTIDES OF IL-2 AND DERIVATIVES THEREOF AND THEIR USE AS THERAPEUTIC AGENTS INSTITUT PASTEUR (FR) 2000-01-27 WO disclosed
EP-0804559-A1 ENZYME FOR CLEAVAGE OF THE ANCHOR REGION OF SURFACE PROTEINS FROM GRAM POSITIVE BACTERIA ROCKEFELLER UNIVERSITY (US) 1997-11-05 EP disclosed
WO-1996011263-A1 ENZYME FOR CLEAVAGE OF THE ANCHOR REGION OF SURFACE PROTEINS FROM GRAM POSITIVE BACTERIA ROCKEFELLER UNIVERSITY (US) 1996-04-18 WO disclosed